ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget An Underutilized Document and Ignored By MB; Deserves Attention Of Congress

January 20, 1989

NCI’s caBIG to Expand For Clinical Informatics Projects.

January 26, 2007

Michigan’s Zhang Wins “Protein Science Olympics”

January 14, 2011

Funding Opportunities

February 28, 2003

In Brief: CT Scanning Reduced Morbidity, Mortality, Helps Deliver Optimal Treatment, Consensus Panel Says

November 27, 1981

RFA: Clinical Correlative Studies In Solid Tumors

April 3, 1992